Reassessing the role of amyloid in isolated REM sleep behavior disorder

Area of Science:

• Neuroscience
• Genetics
• Sleep Medicine

Background:

• Investigating the etiological links between amyloid-beta (Aβ) deposition, isolated REM sleep behavior disorder (iRBD), and Lewy body dementia (LBD) is crucial for understanding neurodegenerative disease progression.
• Mendelian randomization (MR) analysis provides a robust method to infer causal relationships by utilizing genetic variants as instrumental variables, minimizing confounding factors.
• Previous hypotheses suggested a direct causal role for Aβ accumulation in the pathogenesis of iRBD and LBD.

Discussion:

• This study employed MR analysis to rigorously assess the potential causal relationship between genetically predicted cortical Aβ deposition and the risk of iRBD and LBD.
• The analysis revealed no statistically significant causal effect of Aβ deposition on the development or progression of iRBD or LBD.
• These findings challenge the long-held assumption that Aβ plaque formation is a primary driver in the disease pathway of iRBD and LBD.

Key Insights:

• There is no evidence of a causal link between cortical amyloid-beta (Aβ) deposition and isolated REM sleep behavior disorder (iRBD).
• Cortical Aβ deposition does not appear to causally influence the risk or progression of Lewy body dementia (LBD).
• Amyloid accumulation observed in iRBD patients is likely a concurrent pathological feature rather than an initiating cause of the disorder.

Outlook:

• Future research should explore alternative pathological pathways, such as alpha-synuclein aggregation, as primary drivers of iRBD and LBD.
• Investigating the interplay between genetic predisposition, sleep disturbances, and proteinopathies is essential for developing targeted therapeutic strategies.
• Further studies could examine whether Aβ deposition plays a modulatory role in disease severity or progression, even if not causally initiating.